SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
223 hedge funds and large institutions have $2.54B invested in Sage Therapeutics in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 71 increasing their positions, 76 reducing their positions, and 17 closing their positions.
Holders
223
Holders Change
+13
Holders Change %
+6.19%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
71
Reduced
76
Closed
17
Calls
$21.6M
Puts
$16.6M
Net Calls
+$4.98M
Net Calls Change
-$3.09M
Top Buyers
Top Sellers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$50.8M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$37.5M |
| 3 |
3
BlackRock
New York
|
$208M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$108M |
| 5 |
5
Goldman Sachs
New York
|
$24.1M |
